(Q33762450)

29 July 2017

title

In vitro activity of DU-6859a against anaerobic bacteria (English)

1 reference

29 July 2017

4

Finegold SM

1 reference

29 July 2017

Wexler HM

1

1 reference

29 July 2017

Molitoris E

series ordinal

2

1 reference

29 July 2017

Reeves D

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1994

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 July 2017

volume

38

1 reference

29 July 2017

issue

10

1 reference

29 July 2017

page(s)

2504-2509

1 reference

In vitro activity of Bay Y3118 against anaerobic bacteria

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284775

In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284775

Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284775

In vitro activities of three of the newer quinolones against anaerobic bacteria

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284775

In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates

22 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7840599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.38.10.2504

1 reference

29 July 2017

1 reference

29 July 2017

1 reference